Canadian researchers have made cancer treatment history with the success of an intravenous infusion of a virus, JX-594. The virus was injected into 23 patients with advanced and metastasized cancers who had not responded to traditional therapies. Not only was this the first test of viral therapy on human cancer patients, but the first trial to introduce a targeted virus intravenously.
Bud has fallen 204 slots down to number 220 in consumer loyalty among America's top brands during the last quarter century. But a big new campaign - not a new taste, but some new marketing efforts and a newly designed can geared toward attracting young, but legal-age, drinkers - is underway for Budweiser beer.